The number of melanoma cases worldwide is increasing faster than any other cancer and
remains one of the most treatment-refractory malignancies. Despite decades of clinical trials …

In this review an inventory is made of agents used to circumvent cis-
diamminedichloroplatinum (II)(CDDP) resistance in vitro and in vivo. Agents that affect …

Flavonoids are a class of polyphenolic compounds widely distributed in the plant kingdom,
which display a variety of biological activities, including chemoprevention and tumor growth …

The records of 2,673 patients randomized according to seven consecutive Eastern
Cooperative Oncology Group (ECOG) studies of adjuvant therapy for breast cancer were …

PURPOSE: The combination of chemotherapy with immunotherapeutic agents such as
interleukin-2 and interferon alfa-2b has been reported to provide improved treatment results …

We review the current therapy for melanoma. The diagnosis, prognostic variables, staging,
treatment, and follow-up guidelines for cutaneous melanoma are reviewed from the earliest …

Our experience with the combination of dacarbazine, carmustine, cisplatin with and without
tamoxifen is reported. In our initial study, with all 4 drugs, we had an overall response rate of …

This article reviews the published clinical responses of metastatic uveal melanoma and
metastatic cutaneous melanoma with visceral involvement to current therapeutic protocols …

This randomized phase II trial was performed to define the activity and toxicity of the
combination of dacarbazine (DTIC), carmustine (BCNU), cisplatin (DDP) and tamoxifen …

Melanoma metastases were harvested from 82 patients for the purpose of growing and
expanding tumor‐infiltrating lymphocytes (TIL). Tumor tissue cell suspensions were …